Sort
64,565 grants matching “drug discovery”
Drug Discovery Group for Nicotine Dependence Treatment
$517,502Maurizio Fava · Massachusetts General Hospital · U01 · FY2007 · DA
Sugar signaling networks detected by high content fluxomicx
$517,493Wolf B Frommer · Carnegie Institution Of Washington, D.C. · R01 · FY2010 · DK
P7C3 based small molecule for Heart failure treatment
$517,475Srinivas M. Tipparaju · University Of South Florida · R61 · FY2024 · HL
mGluR5 Allosteric Modulators
$517,472Amy Hauck Newman · National Institute On Drug Abuse · Z01 · FY2008 · DA
Intranasal Insulin in a Mouse Model of Alzheimer's Disease
$517,470William A Banks · Seattle Inst For Biomedical/Clinical Res · R01 · FY2014 · AG
Mechanisms of Extinction Memory Enhancement for Cocaine Addiction Treatment
$517,440Kathleen M. Kantak · Boston University (Charles River Campus) · R01 · FY2020 · DA
Mechanisms of Extinction Memory Enhancement for Cocaine Addiction Treatment
$517,440Kathleen M. Kantak · Boston University (Charles River Campus) · R01 · FY2019 · DA
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
$517,434David Oupicky · University Of Nebraska Medical Center · R01 · FY2020 · DK
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
$517,434David Oupicky · University Of Nebraska Medical Center · R01 · FY2022 · DK
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
$517,434David Oupicky · University Of Nebraska Medical Center · R01 · FY2023 · DK
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
$517,434David Oupicky · University Of Nebraska Medical Center · R01 · FY2021 · DK
Structure-function analysis of type IVB secretion systems
$517,416Joseph P Vogel · Washington University · R01 · FY2019 · AI
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis
$517,394Yan Shu · University Of Maryland Baltimore · R01 · FY2024 · DK
Functional and structural correlates of PCSK9 association with lipoproteins
$517,392Nathalie Pamir · Oregon Health & Science University · R01 · FY2021 · HL
SYNTHESIS OF ANTICANCER AGENTS
$517,388K. C. Nicolaou · Scripps Research Institute, The · R01 · FY2010 · CA
Molecular Basis of Cannabinoid Activity
$517,387Alexandros Makriyannis · Northeastern University · R01 · FY2017 · DA
Mapping and Understanding Production of Natural Products in Fungi
$517,365Neil L Kelleher · Northwestern University · R01 · FY2024 · AT
Mechanism of Action
$517,287David R Andes · University Of Wisconsin-Madison · U19 · FY2016 · AI
Scientific and Administrative Management Core
$517,247Nahid Turan · Coriell Institute For Medical Research · U42 · FY2016 · GM
Scientific and Administrative Management Core
$517,247Nahid Turan · Coriell Institute For Medical Research · U42 · FY2019 · GM
SpliceCore: A Cloud-Based Software Platform to Translate Alternative Splicing Events into Therapeutic Targets Using RNA-seq Data
$517,226Martin Akerman · Envisagenics, Inc. · R44 · FY2019 · GM
Computer Modeling of G Protein-Coupled Receptors
$517,225Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Structural Dynamics of Muscle Contraction
$517,192David Dale Thomas · University Of Minnesota · R01 · FY2015 · AR
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support
$517,164Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2023 · AI
Divergent age-dependent peripheral innate immune response following TBI
$517,153Michelle Lee Theus · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · NS